Skip to content

Electrochemical Investigations of L-Cysteine Interactions with Bismuth Ions

MetadataDetails
Publication Date2020-10-06
JournalJournal of The Electrochemical Society
AuthorsGraham T. Cheek, Dela Pena
InstitutionsUnited States Naval Academy
Citations5
AnalysisFull AI Review Included
  • Objective: Elucidate the electrochemical interaction mechanism between L-cysteine and trivalent bismuth (Bi3+) compounds—specifically salicylate, citrate, and nitrate—using cyclic voltammetry (CV) and UV-vis spectroscopy.
  • Electrode Platform: A side-by-side comparison was performed between a standard 3 mm glassy carbon (GC) electrode and a 3 mm boron-doped diamond (BDD) electrode to evaluate redox behavior across highly corrosive pH extremes.
  • pH Windows Modeled: Acidic stomach conditions (pH 1.0, 0.100 M HNO3/HCl, free Bi3+ ion) versus physiological/blood conditions (pH 7.4, MOPS buffer, BiO+ species).
  • Key Finding: Soluble Bi(III)-Cys complexes form at both pH 1.0 and pH 7.4. UV-vis titration confirms a 1:2 Bi3+:Cys stoichiometry in MOPS buffer (saturation at ~50 µL addition).
  • Significance for Medicine: The addition of L-cysteine alters the voltammetric profile of bismuth(III) salicylate (a gastrointestinal pharmaceutical), providing a novel electrochemical pathway to study protein-metal interactions in the digestive tract.
ParameterValueUnitContext
Working Electrodes (BDD)3mmBoron-doped diamond disc (Windsor Scientific/eDAQ)
Working Electrodes (GC)3mmGlassy carbon disc (Bioanalytical Systems)
Reference ElectrodeAg/AgCl—All potentials reported vs Ag/AgCl
Counter Electrode1mmPlatinum wire
Bismuth Concentration1.0mMIn 10.0 mL electrolyte
Supporting Electrolyte (Acid)0.100MHNO3 or HCl
Supporting Electrolyte (Neutral)0.10MMOPS buffer
Operating Temperature22 ± 1°CAmbient laboratory conditions
De-aeration GasN₂—10 min purge pre-scan
Scan Window (Cathodic)−1.0 to +0.8V vs Ag/AgClBi3+ reduction window
Scan Window (Anodic)+0.8 to −0.8V vs Ag/AgClOxidation scan
Polishing Slurry0.05µmBuehler Al2O3 on felt pad
Sonication Time5minAlumina particle removal
Bi:Cys Stoichiometry1:2mol:molConfirmed in pH 7.4 MOPS
Cell Cleaning Agent0.100MK2EDTA overnight soak
Cuvette Path Length1.00cmQuartz, UV-vis
Max Applied Pressure (Cell Hardware)300MPaEL-CELL PAT-Core
  1. Electrode Preparation: Manual polishing of both GC and BDD discs with 0.05 µm alumina slurry, followed by a 5-minute deionized water sonication bath to eliminate particulate contamination.
  2. Solution Preparation: Bismuth compounds dissolved at 1.0 mM in either 0.100 M HNO3/HCl (pH 1.0) or 0.10 M MOPS (pH 7.4); N2 sparged for 10 minutes under magnetic stirring.
  3. Electrochemical Measurement: CV performed on a Gamry Interface 1000 potentiostat sweeping through the Bi3+/Bi0 redox window to track peak shifts upon L-cysteine titration.
  4. Spectroscopic Verification: UV-vis titration on a Jasco V-670 spectrophotometer; L-cysteine added in 10 µL increments to sealed quartz cuvettes to establish binding stoichiometry.
  5. Rigorous Cell Hygiene: All glassware soaked overnight in 0.100 M K2EDTA to prevent Bi3+ carryover between experiments.
Paper Requirement6CCVD Offering
3 mm BDD disc electrode for Bi3+ sensingHeavy / Medium Boron-Doped Polycrystalline Diamond (BDD)
Operation across pH 1.0 ↔ 7.4Chemical-vapor-deposited diamond inert to strong acids
Low background current at negative potentialsBDD wafers polished to Ra < 5 nm available
Confined 3 mm electrode geometryLaser cutting services for custom disc dimensions
  • Applicable Materials: This study demands a highly conductive, wide-potential-window electrode capable of withstanding strong acids (HNO3, HCl) and biological buffers without fouling. 6CCVD’s Boron-Doped Diamond (BDD) meets these exact specifications. The chemical inertness of CVD diamond eliminates the surface oxide layers that plague GC electrodes, delivering clean, reproducible Bi3+/Bi0 redox peaks.
  • Customization Potential: The authors utilize 3 mm discs. 6CCVD routinely supplies BDD wafers up to 125 mm and offers in-house laser cutting to deliver any custom diameter (e.g., 1 mm, 3 mm, 5 mm, 6 mm) with tight dimensional tolerances. Custom metalization (Ti/Pt/Au or Au/Pt/Cu stacks) can be applied for wire-bonded or sealed cell assemblies (e.g., EL-CELL PAT-Core format referenced in this work).
  • Engineering Support: Reproducing or extending this pharmaceutical-electrochemistry work—particularly the cysteine titration experiments—requires electrodes with ultra-low surface contamination. Our in-house PhD engineering team can guide material selection (doping concentration, surface termination, polishing grade) to optimize signal-to-noise for trace metal speciation.
  • Call to Action: For custom specifications or material consultation, visit 6ccvd.com or contact our engineering team directly.
View Original Abstract

The interaction of L-cysteine with bismuth compounds bismuth(III) salicylate, bismuth(III) citrate, and bismuth(III) nitrate, was studied at pH 1.0 (0.100 M HNO 3 and 0.100 M HCl) and pH 7.4 MOPS buffer by cyclic voltammetry at glassy carbon and boron-doped diamond electrodes. pH 1.0, at which bismuth (III) exists as the simple Bi 3+ ion, was chosen to approximate the acid strength of stomach contents. pH 7.4, at which bismuth(III) exists as BiO, was used for its similarity to general physiological conditions. The amino acid L-cysteine was chosen because its sulfhydryl group undergoes intense interaction with many metal cations, serving as a model for cysteine-containing proteins in the digestive system. It was determined that Bi(III) and L-cysteine (Cys) form soluble complexes at both pH 1.0 and pH 7.4. UV-vis spectroscopic investigations support interaction of Bi(III) and L-cysteine to form a 1:2 Bi(III): Cys complex in pH 7.4 MOPS buffer. L-cysteine addition to solutions of the pharmaceutical bismuth(III) salicylate was found to alter the voltammetric behavior of the salicylate complex. These results, especially at pH 1.0, are relevant to understanding the interaction of various cysteine-containing proteins in the human digestive system with bismuth pharmaceuticals and may help guide future explorations of bismuth formulations.